Forgot your password?

Forgot your username?

BEAT BioTherapeutics Corp.

1380-112th Avenue NE Suite 200
Bellevue, WA 98004
Click for website
Research Sector Biotechnology
Summary Description Therapies for heart disease, based on a fundamental discovery in cardiac muscle contraction

Click here for Financial Data KeywordsHeart Disease, Cardiac Failure, Gene Therapy, heart, cardiology, cardio, datp


BEAT BioTherapeutics Corp. (BEATBio) is a biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle co......view more

Technology / Differentiation

The founders? discovery employs a novel biological agent for therapeutic use by raising the production of DeoxyAdenosine Triphosphate (dATP) in the metabolic synthesis of ATP. Essentially, the heart?s...view more

Market / Customers

26 million people worldwide survive after suffering from heart failure. The market for heart disease therapeutics was $3 B in 2005 and grew at a Compound Annual Growth Rate of 4.5% to reach $4.1 B in ......view more

Revenue / Funding

Funding to date - $3M; Financing sought ? Series A preferred equity, up to $18M...view more


Cooley LLP...view more


Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/onemedpl/public_html/include/counter.php on line 10